Cipla Q4 profit exceeds 72% to Rs 411.5 crore, losing ratings in all profit parameters
Pharma’s company Cipla on May 14 experienced a healthy annual growth combined with a combined profit of Rs 411.5 crore operated annually. Earnings in all parameters have lost analysts’ expectations. Consolidated revenue grew by 5.3 percent annually to Rs 4,606.4 crore in Q4FY21, North American business showed 17 percent YoY growth and Indian business growth …
Cipla Q4 profit exceeds 72% to Rs 411.5 crore, losing ratings in all profit parameters Read More »